Johannes M. Froehlich

Antidiabetic PPARγ-Activator Rosiglitazone Reduces MMP-9 Serum Levels in Type 2 Diabetic Patients With Coronary Artery Disease

Nikolaus Marx, Johannes M. Froehlich, Laila Siam et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2003 · 257 citations

Combined Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced and Diffusion-Weighted Magnetic Resonance Imaging Reliably Detect Pelvic Lymph Node Metastases in Normal-Sized Nodes of Bladder and Prostate Cancer Patients

Harriet C. Thoeny, Maria Triantafyllou, Frédéric D. Birkhaeuser et al. · European Urology · 2009 · 243 citations

Urogenital Radiology, Iron Oxide–enhanced, Urology +12

Effect of Rosiglitazone Treatment on Soluble CD40L in Patients With Type 2 Diabetes and Coronary Artery Disease

Nikolaus Marx, Armin Imhof, Johannes M. Froehlich et al. · Circulation · 2003 · 214 citations · Full text

Metastases in Normal-sized Pelvic Lymph Nodes: Detection with Diffusion-weighted MR Imaging

Harriet C. Thoeny, Johannes M. Froehlich, Maria Triantafyllou et al. · Radiology · 2014 · 202 citations

Combined Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced and Diffusion-weighted Magnetic Resonance Imaging Facilitates Detection of Metastases in Normal-sized Pelvic Lymph Nodes of Patients with Bladder and Prostate Cancer

Frédéric D. Birkhäuser, Urs E. Studer, Johannes M. Froehlich et al. · European Urology · 2013 · 172 citations

Urogenital Radiology, Magnetism, Iron Oxide–enhanced +12